pargyline has been researched along with tetragastrin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fink, H; Marsden, CA; Morgenstern, R; Reum, T; Schäfer, U | 1 |
1 other study(ies) available for pargyline and tetragastrin
Article | Year |
---|---|
Cholecystokinin increases extracellular dopamine overflow in the anterior nucleus accumbens via CCK(B) receptors in the VTA assessed by in vivo voltammetry.
Topics: Animals; Benzodiazepinones; Cholecystokinin; Devazepide; Dopamine; Dose-Response Relationship, Drug; Electrophysiology; Extracellular Space; Hormone Antagonists; Male; Microinjections; Monoamine Oxidase Inhibitors; Nucleus Accumbens; Pargyline; Phenylurea Compounds; Rats; Rats, Wistar; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Sincalide; Tetragastrin; Ventral Tegmental Area | 1997 |